Article thumbnail

Unexpectedly high burden of rotavirus gastroenteritis in very young infants

By H Fred Clark, Amy E Marcello, Diane Lawley, Megan Reilly and Mark J DiNubile
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1988). AJ: Prospective longitudinal study of rotavirus infections in children from birth to two years of age in Central Africa. Ann Inst Pasteur Virol
  2. (2004). Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season.
  3. (2009). Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA
  4. (2008). BJ: Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr Infect Dis J
  5. (2009). Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine
  6. (2000). C: Seasonal and age distribution of rotavirus infection in Porto Alegre-Brazil.
  7. (2006). Castillo-Chavez C: An age-structured epidemic model of rotavirus with vaccination.
  8. (1982). Chonmaitree T: Incidence of rotavirus infection in different age groups of pediatric patients with gastroenteritis.
  9. (1997). Diarrhea- and rotavirusassociated hospitalizations among children less than 5 years of age: United States,
  10. (2006). Disease Control: Prevention of rotavirus gastroenteritis among infants and children. MMWR
  11. (2006). Disease Control: Rotavirus vaccination coverage and adherence to the advisory committee on immunization practices (ACIP)-recommended vaccination schedule - United States,
  12. (1977). Distribution and titres of rotavirus antibodies in different age groups. J Hyg (Lond)
  13. (1998). Epidemiology of diarrheal disease among children enrolled in four West Coast health maintenance organizations. Vaccine Safety Datalink Team. Pediatr Infect Dis J
  14. (1987). FE: Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report. Pediatr Infect Dis J
  15. (1997). Glass RI: Rotavirus in Ireland: national estimates of disease burden,
  16. (1994). High prevalence of rotavirus infection among neonates born at hospitals in Delhi, India: predisposition of newborns for infection with unusual rotavirus. Ped Infect Dis J
  17. (2009). Hodinka RL: Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine. Clin Vaccine Immunol
  18. (2009). Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics
  19. (1993). Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States,
  20. (1976). Human reovirus-like agent as the major pathogen associated with &quot;winter&quot; gastroenteritis in hospitalized infants and young children.
  21. (2006). Impact of acute rotavirus gastroenteritis on pediatric outpatient practices in the United States. Pediatr Infect Dis J
  22. (2008). Implementation of rotavirus immunization in Philadelphia, Pennsylvania: high levels of vaccine ineligibility and off-label use. Pediatrics
  23. (2001). Incidence of hospitalizations due to rotavirus gastroenteritis in Denmark. Acta Paediatr
  24. (2007). Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics
  25. (2006). Iosef C: Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine. Vaccine
  26. (2004). IP: Epidemiologic and clinical characteristics of rotavirus disease during five years of surveillance in Venezuela. Pediatr Infect Dis J
  27. (2006). Kapikian AZ: Neonatal administration of rhesus rotavirus tetravalent vaccine. Pediatr Infect Dis J
  28. (2004). L: Hospitalizations for gastroenteritis: the role of rotavirus. Vaccine
  29. (1987). Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations. Pediatr Infect Dis J
  30. (2005). Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis.
  31. (1986). Ogra PL: The effects of infant feeding on rotavirus-induced gastroenteritis: a prospective study. Am J Public Health
  32. (2004). Oyaguez I, Gonzalez A: Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000. Vaccine
  33. (2003). RI: Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis
  34. (1979). RI: Trends in hospitalizations for diarrhea in United States children from
  35. (1991). RI: Visualizing geographic and temporal trends in rotavirus activity in the United States,
  36. (1980). Rotavirus gastroenteritis in the Washington, DC, area: incidence of cases resulting in admission to the hospital.
  37. (2006). Rotavirus hospitalisation in New Zealand children under 3 years of age.
  38. (2000). Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med
  39. (2005). Rotaviruses: Principles and Practice of Infectious Diseases. Sixth edition. Edited by:
  40. (2009). Rotaviruses: Textbook of Pediatric Infectious Diseases. Sixth edition.
  41. (2007). S: A prospective study of rotavirus diarrhea in children under 1 year of age. Clin Pediatr (Phila)
  42. (2006). Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
  43. (2006). Safety and efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine in preventing rotavirus gastroenteritis and reducing associated healthcare resource utilization.
  44. (2007). Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J
  45. (1990). Serotypes and electropherotypes of human rotavirus in the USA: 1987-1989. J Infect Dis
  46. (2008). The clinical and molecular epidemiology of community- and healthcare-acquired rotavirus gastroenteritis. Pediatr Infect Dis J